Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20852, United States.
Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20852, United States.
Microbes Infect. 2017 Feb;19(2):91-100. doi: 10.1016/j.micinf.2016.12.001. Epub 2016 Dec 10.
Respiratory infection of mice with Francisella novicida has recently been used as a model for the highly virulent human pathogen Francisella tularensis. Similar to F. tularensis, even small doses of F. novicida administered by respiratory routes are lethal for inbred laboratory mice. This feature obviously limits study of infection-induced immunity. Parenteral sublethal infections of mice with F. novicida are feasible, but the resulting immune responses are incompletely characterized. Here we use parenteral intradermal (i.d.) and intraperitoneal (i.p.) F. novicida infections of C57BL/6J mice to determine the role of B cells in controlling primary and secondary F. novicida infections. Despite developing comparable levels of F. novicida-primed T cells, B cell knockout mice were much more susceptible to both primary i.d. infection and secondary i.p. challenge than wild type (normal) C57BL/6J mice. Transfer of F. novicida-immune sera to either wild type C57BL/6J mice or to B cell knockout mice did not appreciably impact survival of subsequent lethal F. novicida challenge. However, F. novicida-immune mice that were depleted of T cells after priming but just before challenge survived and cleared secondary i.p. F. novicida challenge. Collectively these results indicate that B cells, if not serum antibodies, play a major role in controlling F. novicida infections in mice.
弗氏柠檬酸杆菌呼吸道感染最近被用作高度毒力的人类病原体土拉弗朗西斯菌的模型。与土拉弗朗西斯菌相似,即使通过呼吸道给予小剂量的弗氏柠檬酸杆菌,也会导致近交系实验小鼠致命。这一特征显然限制了对感染诱导免疫的研究。通过呼吸道给予弗氏柠檬酸杆菌亚致死剂量的小鼠进行实验是可行的,但由此产生的免疫反应尚未完全描述。在这里,我们使用弗氏柠檬酸杆菌经皮(皮内)和腹腔内(腹腔内)感染 C57BL/6J 小鼠,以确定 B 细胞在控制原发性和继发性弗氏柠檬酸杆菌感染中的作用。尽管弗氏柠檬酸杆菌初免 T 细胞产生的水平相当,但与野生型(正常)C57BL/6J 小鼠相比,B 细胞敲除小鼠对原发性皮内感染和继发性腹腔内挑战都更为敏感。将弗氏柠檬酸杆菌免疫血清转移至野生型 C57BL/6J 小鼠或 B 细胞敲除小鼠中,对随后的致死性弗氏柠檬酸杆菌挑战的存活没有明显影响。然而,在初免后但在挑战前耗尽 T 细胞的弗氏柠檬酸杆菌免疫小鼠存活并清除了继发性腹腔内的弗氏柠檬酸杆菌挑战。总的来说,这些结果表明 B 细胞(如果不是血清抗体)在控制小鼠弗氏柠檬酸杆菌感染中起主要作用。